drugset / Trial / NCT05146843
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients
Unknown
44 enrolled
D'Or Institute for Research and Education
InCor Heart Institute · collabInstituto do Cancer do Estado de São Paulo · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Investigate the protective effect of chronic MitoQ supplementation on cardiovascular toxicity induced by doxorubicin-based adjuvant chemotherapy in breast cancer patients.
Timeline
- Start
- 2022-06-02
- Primary completion
- 2022-11-01
- Completion
- 2023-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MitoQ | Small molecule | 20 mg | — |